Skip to content

Clinical trials

Phase 1 Hemorrhage trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 1 Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20072
20102
20112
20121
20135
20144
20151
20161
20172
20181
20191
20211
20224
20232
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Unknown status7
Recruiting4
Withdrawn3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University2
Regeneron Pharmaceuticals2
Zynex Monitoring Solutions2
Alex Ekwueme Federal University Teaching Hospital1
Beijing Tiantan Hospital1
Biomedica Management Corporation1
Boehringer Ingelheim1
Cayuga Biotech, Inc.1
Cellphire Therapeutics, Inc.1
Corewell Health East1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage39
Cerebral Hemorrhage3
Hemostatic Disorders3
Thrombocytopenia3
Thrombosis3
Blood Loss, Surgical2
Hematologic Diseases2
Abdominal Pain1
Anemia1
Anemia, Aplastic1

Trials

Showing 26 to 39 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.